Hexadecylphosphoserine (TFA)

Hexadecylphosphoserine TFA is a phospholipid molecule that contains a long-chain alkyl (hexadecyl) and a phosphoserine group, giving it a high affinity for the cell membrane. Hexadecylphosphoserine TFA can exert antitumor activity by modulating [Ca++]i and its related signaling pathways, making it useful for research in the field of breast cancer[1].

Product Specifications

UNSPSC

12352211

Target

Calcium Channel

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Cancer-programmed cell death

Field of Research

Cancer

Purity

98.0

Smiles

OC([C@@H](N)COP(OCCCCCCCCCCCCCCCC)(O)=O)=O.OC(C(F)(F)F)=O

Molecular Formula

C21H41F3NO8P

Molecular Weight

523.52

References & Citations

[1]Bergmann J, et al. Multiple effects of antitumor alkyl-lysophospholipid analogs on the cytosolic free Ca2+ concentration in a normal and a breast cancer cell line. Anticancer Res. 1994 Jul-Aug;14 (4A) :1549-56.